Elicio Therapeutics (ELTX) Stock Insights

ELTX price $1.84 +0.01 +0.55%

Ticker
ELTX
Price
$1.84
Change
+0.01 +0.55%
Market cap ?
$35.08M
Beta ?
1.98
Sector
Healthcare
Industry
Biotechnology

Fair value

ELTX fair value $2,021.48. Price $1.84. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 8.07M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 19.07M. Net debt -4.05M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ELTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.44——
2026-08-13-0.43-0.54——
2026-05-11-0.65-0.49——
2026-03-12-0.49-0.47——
2025-11-13-0.60-0.62——
2025-08-07-0.66-0.69——
2025-05-13-0.87-0.67——
2025-03-31-1.02-0.94——
2024-11-13-1.39-0.73——
2024-08-13-0.64-0.96——
2024-05-15-1.15-1.09——
2024-03-29-3.77-0.79——
2023-11-09-1.27-0.80——
2023-08-11-2.61-5.70—800.00K
2023-05-10-2.51-5.40—800.00K
2023-03-17-0.21-2.10—800.00K
2022-11-14-3.00-3.20—625.00K
2022-08-15-3.00-4.63653.00K1.35M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-31ADAMS JULIANBuy21.75K$2.7058.73K
2026-08-31Ashe Carol GailBuy21.75K$2.7058.73K
2026-08-31Chudnovsky YekaterinaBuy21.75K$2.7058.73K
2026-08-31Nissenson AllenBuy21.75K$2.7058.73K
2026-08-31RUFFOLO ROBERT RBuy21.75K$2.7058.73K
2026-08-31WILSON KAREN JBuy21.75K$2.7058.73K
2026-08-31Venkatesan JayBuy21.75K$2.7058.73K
2026-07-16Haqq ChristopherBuy64.64K$3.20206.86K
2026-07-16DeMuth PeterBuy52.83K$3.20169.06K
2026-07-16Shah PreetamBuy60.83K$3.20194.67K
2026-07-16Connelly RobertBuy186.94K$3.20598.22K
2026-02-02Connelly RobertBuy147.20K$8.101.19M
2026-02-02Connelly RobertBuy73.60K——
2026-02-02Shah PreetamBuy47.90K$8.10387.99K
2026-02-02Shah PreetamBuy24.00K——
2026-02-02DeMuth PeterBuy41.60K$8.10336.96K
2026-02-02DeMuth PeterBuy20.80K——
2026-02-02Haqq ChristopherBuy25.40K——
2026-02-02Haqq ChristopherBuy50.90K$8.10412.29K
2025-12-09DeMuth PeterBuy362$4.411.60K
2025-12-09DeMuth PeterSell362$4.411.60K
2025-06-03Chudnovsky YekaterinaBuy103.22K$7.75799.99K
2025-05-19Ashe Carol GailBuy7.90K$5.8446.14K
2025-05-19Nissenson AllenBuy7.90K$5.8446.14K
2025-05-19Venkatesan JayBuy7.90K$5.8446.14K
2025-05-19ADAMS JULIANBuy7.90K$5.8446.14K
2025-05-19WILSON KAREN JBuy7.90K$5.8446.14K
2025-05-19RUFFOLO ROBERT RBuy7.90K$5.8446.14K
2025-05-19Chudnovsky YekaterinaBuy7.90K$5.8446.14K
2025-04-15Shah PreetamBuy191.62K$4.98954.29K
2025-03-24Shah PreetamOther0——
2025-03-05Chudnovsky YekaterinaBuy3.50M$5.8120.34M
2025-03-05Chudnovsky YekaterinaSell3.44M$5.8120.00M
2025-02-03DeMuth PeterBuy44.40K$8.92396.05K
2025-02-03Haqq ChristopherBuy44.00K$8.92392.48K
2025-02-03Connelly RobertBuy121.60K$8.921.08M
2024-12-16DeMuth PeterBuy381$4.411.68K
2024-12-16DeMuth PeterSell381$4.411.68K
2024-11-26Venkatesan JayBuy50.00K$0.01500
2024-11-26Venkatesan JaySell50.00K$0.01500
2024-11-21WILSON KAREN JBuy4.10K$5.1220.99K
2024-11-21ADAMS JULIANBuy4.10K$5.1220.99K
2024-11-21Ashe Carol GailBuy4.10K$5.1220.99K
2024-11-21Venkatesan JayBuy4.10K$5.1220.99K
2024-11-21RUFFOLO ROBERT RBuy4.10K$5.1220.99K
2024-11-21Chudnovsky YekaterinaBuy4.10K$5.1220.99K
2024-11-21Nissenson AllenBuy4.10K$5.1220.99K
2024-09-30Connelly RobertBuy91.60K$5.03460.75K
2024-09-30DeMuth PeterBuy29.80K$5.03149.89K
2024-09-30Haqq ChristopherBuy28.20K$5.03141.85K
2024-08-12Chudnovsky YekaterinaBuy3.44M$5.8120.00M
2024-06-28Venkatesan JayBuy50.00K$5.00250.00K
2024-06-28Venkatesan JayBuy50.00K$0.01500
2024-06-28Chudnovsky YekaterinaBuy1.60M$5.008.00M
2024-06-28Chudnovsky YekaterinaBuy1.60M$0.0116.00K
2024-03-19Chudnovsky YekaterinaBuy1.03M$0.0110.33K
2024-02-01Piekos BrianBuy43.23K$4.50194.51K
2024-02-01Connelly RobertBuy225.14K$4.501.01M
2024-02-01Haqq ChristopherBuy28.20K$4.50126.90K
2024-02-01DeMuth PeterBuy29.80K$4.50134.10K
2024-02-01DeMuth PeterBuy342$4.501.54K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 67, holders +14 vs prior quarter. Ownership 20.55%.

HolderSharesChangeChange %Value
KNOLL CAPITAL MANAGEMENT, LLC1.21M581.04K+92.10%4.74M
BLACKROCK, INC.766.00K715.41K+1413.93%3.00M
VANGUARD CAPITAL MANAGEMENT LLC572.15K53.51K+10.32%2.24M
CAPTION MANAGEMENT, LLC418.10K418.10KNew1.63M
GEODE CAPITAL MANAGEMENT, LLC311.35K176.19K+130.35%1.22M
TORONTO DOMINION BANK200.00K200.00KNew782.00K
SUSQUEHANNA INTERNATIONAL GROUP, LLP181.40K136.30K+302.22%709.27K
STATE STREET CORP179.42K128.80K+254.44%701.53K
CAPTION MANAGEMENT, LLC165.70K165.70KNew647.89K
JANE STREET GROUP, LLC153.60K140.00K+1029.41%600.58K
CITADEL ADVISORS LLC134.20K118.22K+739.90%524.72K
NORTHERN TRUST CORP130.16K70.43K+117.90%508.93K
DIADEMA PARTNERS LP112.10K112.10KNew438.31K
IKARIAN CAPITAL, LLC107.10K107.10KNew418.76K
IKARIAN CAPITAL, LLC100.00K100.00KNew391.00K
DIADEMA PARTNERS LP100.00K100.00KNew391.00K
SUSQUEHANNA INTERNATIONAL GROUP, LLP90.10K45.00K+99.78%352.29K
VANGUARD PORTFOLIO MANAGEMENT LLC88.91K88.91KNew347.62K
VANGUARD FIDUCIARY TRUST CO88.06K18.87K+27.28%344.32K
ALLIANCEBERNSTEIN L.P.81.28K81.28KNew317.81K
UBS GROUP AG40.42K6.65K+19.69%158.04K
JANE STREET GROUP, LLC32.40K18.80K+138.24%126.68K
BOOTHBAY FUND MANAGEMENT, LLC32.40K32.40KNew126.68K
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.31.71K31.71KNew123.97K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC31.71K31.71KNew123.97K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Elicio Therapeutics (ELTX) Stock Insights

ELTX$1.84+0.01 +0.55%

$35.08M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History